Background & Aims Irritable bowel syndrome (IBS) is a common chronic functional bowel
disorder for which patients take significant risks to ameliorate symptoms. Unfortunately, there …

Background Adjuvant immunotherapy is revolutionising care for patients with resected stage
III and IV melanoma. However, immunotherapy may be associated with toxicity, making …

The present study investigates fertility intentions of men, aged 18–59, as expressed in
willingness to cryopreserve sperm for future use in procreation. An economic stated …

Objective. This study investigates potential of a new financial incentive policy, the GP-
referral discount scheme introduced in Singapore, in reducing nonurgent emergency …

Background Recent drug approvals have increased the number of therapies available for
inflammatory bowel disease (IBD), making it difficult for patients to navigate available …

We found the review written by Hirten et al 1 timely, published at the height of the COVID-19
pandemic, when pervasive concerns about immunomodulators or biologic drugs prevailed …

Background Many patients with irritable bowel syndrome (IBS) experience acute and
unexpected pain episodes over and above chronic background symptoms, and there are …

The presented studies reviewed in this chapter support efforts for increased consideration of
patient benefit as an essential quality criterion in the assessment of integrated care …

In modern medicine, any medical intervention has to be supported by a patient's informed
consent. Challenges to this process include the specificity and complexity of medical …

There is currently no cure for inflammatory bowel disease. Most recent treatments and
treatment strategies allow for healing intestinal lesions and maintaining steroid-free …